![]() |
Volumn 41, Issue 11, 2015, Pages 2022-2023
|
Antimicrobial de-escalation in septic cancer patients: is it safe to back down?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTIC AGENT;
ANTIINFECTIVE AGENT;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
CANCER CENTER;
CANCER MORTALITY;
CANCER PATIENT;
HUMAN;
INTENSIVE CARE UNIT;
LENGTH OF STAY;
LETTER;
MIXED INFECTION;
PATIENT SAFETY;
PRACTICE GUIDELINE;
RETROSPECTIVE STUDY;
SEPSIS;
SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE;
TREATMENT DURATION;
AGED;
CAUSE OF DEATH;
COMPLICATION;
DRUG EFFECTS;
ECONOMICS;
EPIDEMIOLOGY;
FEMALE;
HOSPITAL MORTALITY;
MALE;
MIDDLE AGED;
MORTALITY;
NEOPLASMS;
NEW YORK;
STATISTICS AND NUMERICAL DATA;
AGED;
ANTI-INFECTIVE AGENTS;
CANCER CARE FACILITIES;
CAUSE OF DEATH;
DRUG RESISTANCE, MICROBIAL;
FEMALE;
HOSPITAL MORTALITY;
HUMANS;
INTENSIVE CARE UNITS;
LENGTH OF STAY;
MALE;
MIDDLE AGED;
NEOPLASMS;
NEW YORK CITY;
RETROSPECTIVE STUDIES;
SEPSIS;
|
EID: 84942503933
PISSN: 03424642
EISSN: 14321238
Source Type: Journal
DOI: 10.1007/s00134-015-4016-6 Document Type: Letter |
Times cited : (33)
|
References (3)
|